戻る Agenda
Session 4: Advancing External Control Arms and Digital Twins for Principled Regulatory Use
Session Chair(s)
Representative Invited
Amgen, United States
Advancing External Control Arms and Digital Twins for Principled Regulatory Use
Speaker(s)
Representative Invited
Senior Director, Datavant, United States
Externally controlled trials using real-world data: Adapting SPIFD2 to ensure principled design and data selection (SPIFD-ECT)
Representative Invited
Senior Science Policy Analyst, Friends of Cancer Research, United States
Advancing External Control Arms for Regulatory Use: Lessons from a Multi-Stakeholder Pilot